MARKET

ZURA

ZURA

Zura Bio Limited
NASDAQ
6.99
+0.09
+1.30%
After Hours: 7.06 +0.07 +1.00% 17:21 03/11 EDT
OPEN
7.03
PREV CLOSE
6.90
HIGH
7.12
LOW
6.80
VOLUME
307.95K
TURNOVER
--
52 WEEK HIGH
7.44
52 WEEK LOW
0.9700
MARKET CAP
602.66M
P/E (TTM)
-10.4547
1D
5D
1M
3M
1Y
5Y
1D
Zura Bio Updates Corporate Outlook on Lead Tibulizumab Program
TipRanks · 1d ago
Weekly Report: what happened at ZURA last week (0302-0306)?
Weekly Report · 2d ago
13D Filings
Barron‘s · 5d ago
Zura Bio Ltd. Files Initial Statement of Beneficial Ownership for Director Ajay Nirula
Reuters · 6d ago
Zura Bio Highlights TibuSURE Phase 2 Trial Design
TipRanks · 6d ago
Zura Bio Unveils Phase 2 TibuSURE Trial Design for Tibulizumab in Systemic Sclerosis
Reuters · 6d ago
Zura Bio Says Design Of Its Ongoing Phase 2 TibuSURE Clinical Trial Evaluating Tibulizumab In SSc Accepted For Presentation At Systemic Sclerosis World Congress
Benzinga · 6d ago
Zura Bio to Present Phase 2 TibuSURE Study Design Poster at 9th Systemic Sclerosis World Congress
Reuters · 6d ago
More
About ZURA
Zura Bio Limited is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies. It is developing a portfolio of therapeutic indications for tibulizumab (ZB-106), crebankitug (ZB-168), and torudokimab (ZB-880) with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases, including systemic sclerosis and other indications with unmet needs. ZB-106 is an immunoglobulin G single-chain variable fragment bispecific dual-antagonist antibody engineered by the fusion of TALTZ and tabalumab that neutralize interleukin-17A (IL-17A) and BAFF. ZB-168 is a fully human, high affinity monoclonal antibody that binds and neutralizes the IL-7 receptor chain alpha chain. ZB-880 is a fully human, high affinity monoclonal antibody that neutralizes IL-33, preventing ST2-dependent and ST2-independent inflammation.

Webull offers Zura Bio Ltd stock information, including NASDAQ: ZURA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ZURA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ZURA stock methods without spending real money on the virtual paper trading platform.